NCT05645523
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
StatusRecruiting
PhaseEarly Phase 1
Primary completion (estimated)
At risk: Primary completion moved at least 11 months later.
See at-risk trials from St. Jude Children's Research Hospital
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 22 versions: 20 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Dec 2026 to Dec 2027
- Eligibility criteria expanded, about 5 words
- Enrollment increased: 25 → 35 participants
- Site details revised at 3 of 3 sites
- Minor Site contacts updated at 1 of 3 sitesv21
- Notable Enrollment target: 15 to 25
- Site contacts updated at 1 of 3 sites
- Minor Study sites: 1 to 3v18
- Minor Site contact updatedv17
Show 14 earlier versionsHide 14 earlier versions
- Notable Primary and study completion dates: Dec 2025 to Dec 2026
- Eligibility criteria expanded, about 8 words
- Primary endpoints revised (2)
- Minor Start date changed from estimate of Nov 2023 to Oct 24, 2023v14
- Minor Start date: Oct 2023 to Nov 2023v13
- Minor Start date: Sep 2023 to Oct 2023v12
- Minor Start date: Aug 2023 to Sep 2023v11
- Notable Trial status: Not Yet Recruiting to Recruiting
- Site details revised
- Minor Start date: Jul 2023 to Aug 2023v9
- Minor Start date: Jun 2023 to Jul 2023v8
- Minor Start date: May 2023 to Jun 2023v7
- Minor Start date: Apr 2023 to May 2023v6
- Minor Start date: Mar 2023 to Apr 2023v5
- Minor Start date: Feb 2023 to Mar 2023v4
- Minor Start date: Jan 2023 to Feb 2023v3
- Minor Start date: Dec 2022 to Jan 2023v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Percentage of patients in whom Indocyanine Green (ICG)-guided sentinel lymph node (SLN) mapping was successful
Timeframe: During surgery (Intraoperatively)
Percentage of patients with grade 3 or higher adverse events related to ICG use
Timeframe: From the time of ICG administration to 24 hours after surgery (post-surgery)
Arms and interventions
Indocyanine green (ICG)Experimental
Participants will receive Indocyanine green intraoperatively.
Drugs: Indocyanine Green
Sites
3 sites in 1 country